Medsafe blocks sales of Covid-19 'treatment' Artemisia annua

Medsafe has won praise for moving quickly to stop sales of a herbal remedy linked to Covid-19.

Frontiers Prevalence of self-medication during COVID-19 pandemic: A systematic review and meta-analysis

The Global Science and Politics of Covid-19 / SARS-CoV-2

Artemisia annua, an inexpensive alternative to Covid-19 - very promising leads! - La Maison de l'Artemisia - This plant can save millions of lives

COVID-19 Lockdown Exit Analysis

Cost-Utility and Cost-Effectiveness Analysis of disease-modifying drugs of Relapsing-Remitting Multiple Sclerosis: A Systematic Review

Skyclarys (Omaveloxolone) Becomes the First FDA-Approved Treatment for Friedreich's Ataxia - Xtalks

COVID-19 Lockdown Exit Analysis

A Pilot Study of Ocrelizumab Infusion Reaction Rates Among Multiple Sclerosis Patients Treated in a Hospital and 2 Outpatient Sites of Care - National Home Infusion Association

Artemisia and Artemisia-based products for COVID-19 management: current state and future perspective